Navigation

Home
Team
Companies
News & Ideas
Careers
Investor Portal
Contact Us

Address

Bold Capital Partners
225 Santa Monica Blvd.
Suite 900
Santa Monica
CA 90401

Google Maps

Contacts

Email us

Socials

LinkedIn

Recent Investments

Form Bio

Form Bio

Syntis Bio

Gameto

Insilico Medicine

- Insilico Medicine - Insilico Medicine -

Insilico is utilizing and developing the latest innovations in artificial intelligence to bridge the gap between biomarker development and drug discovery. Insilico’s comprehensive drug discovery engine drastically reduces the time and cost of identifying promising drug candidates.

Visit Company Website

Alex Zhavoronkov CEO

Technologies

Applied AI,

Biotechnology,

Computational Biology

Follow

Company News

View All News

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19

Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis

Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis

Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle

Insilico Medicine’s AI-Designed Fibrosis Drug Passes Phase I Hurdle

Insilico Medicine CEO Alex Zhavoronkov Featured Among World’s Top 50 Innovators

Insilico Medicine CEO Alex Zhavoronkov Featured Among World’s Top 50 Innovators

Insilico Medicine Boosts Latest Funding Round to $95 Million with Aramco Backing

Insilico Medicine Boosts Latest Funding Round to $95 Million with Aramco Backing

Insilico Medine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-Powered Drug Discovery Robotics Laboratory

Insilico Medine Raises $60 Million in Series D Financing to Advance Pipeline and Launch AI-Powered Drug Discovery Robotics Laboratory

Jobs

Interested in a job at Insilico Medicine?

Deciduous Therapeutics

Next